Lifecore Biomedical Inc (NAS:LFCR)
$ 7.6 0.57 (8.11%) Market Cap: 279.88 Mil Enterprise Value: 411.23 Mil PE Ratio: 152.00 PB Ratio: 0 GF Score: 69/100

Q4 2022 Landec Corp Earnings Call Transcript

Aug 10, 2022 / 09:00PM GMT
Release Date Price: $11.02 (+2.04%)
Operator

Good afternoon, and thank you for joining Landec's Fiscal 2022 Fourth Quarter Earnings Call. (Operator Instructions) Now I would like to turn the call over to Jeff Sonnek, Investor Relations at ICR. Thank you, sir. You may begin.

Jeff Sonnek
ICR, LLC - SVP

Good afternoon, and thank you for joining us to discuss Landec Corporation's Fourth Quarter Fiscal 2022 Earnings Results. In connection with today's announcement, I'd also like to draw your attention to the investor presentation on Landec's Investor Relations website as well as a separate press release concerning the corporate transition to Lifecore that is now underway. In connection with that announcement, Jim Hall has been named CEO of Landec and elected to the Board of Directors. Jim will lead today's call alongside John Morberg, Landec's Chief Financial Officer.

Before we begin, we'd like to remind everyone of the safe harbor statement. Certain statements made in the course of this call may contain forward-looking statements. It is important to note that the company's actual results could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot